In San Kim

Fusion polypeptide in which anti-inflammatory polypeptide and ferritin monomer fragment are bound and pharmaceutical composition for preventing and treating inflammatory diseases, containing same as active ingredient

Human-derived ferritin monomer fragment and fusion polypeptide using same

CYCLIC PEPTIDE SPECIFICALLY BINDING TO APOPTOTIC CELLS AND USE THEREOF

Methods of inhibiting pathological angiogenesis with doppel-targeting molecules

Methods of inhibiting pathological angiogenesis with doppel-targeting molecules

Human ferritin-derived fusion polypeptide

Drug Delivery Conjugate Capable of Controlled Release, and Use Thereof

Drug-fluorophore complex for specific detection of tumor cells

Fusion peptide comprising dhFas-1 domain and MMP substrate and use thereof for preventing and treating rheumatoid arthritis

Protein skeletal module which increases the binding affinity and binding specificity of active polypeptides

Peptides for targeting apoptotic cells and uses thereof

Target-aiming drug delivery system for diagnosis and treatment of cancer containing liposome labeled with peptides which specifically targets interleukin-4 receptors, and manufacturing method thereof

Peptide which passes through blood-brain barrier and targets apoptosis of neurodegenerative brain disease site and uses thereof

USES OF APOPTOTIC CELL-TARGETING PEPTIDES, LABEL SUBSTANCES AND LIPOSOMES CONTAINING A THERAPEUTIC AGENT FOR PREVENTING, TREATING OR THERAPEUTICALLY DIAGNOSING APOPTOSIS-RELATED DISEASES

Stroke-targeting peptide and use thereof

Peptides for targeting apoptotic cells and uses thereof

Recombinant vector expressing MDR1 shRNA and thymidine kinase and use thereof

Polypeptide specifically bound to phosphatidylserine and the use thereof

Anticancer drug-chitosan complex forming self-aggregates and preparation method thereof

Peptide for diagnosing, preventing and treating atherosclerosis and uses thereof

Monoclonal Antibody to Human TGF-Beta Induced Gene-H3 and Use Thereof

Method and pharmaceutical composition for preventing or treating diseases associated with inflammation

NOVEL USE OF LIGANDS SPECIFIC TO FEX-2 POLYPEPTIDE

Method for Producing Epidermal Growth Factor Using Fusion Proteins Comprising Fas-1 Domain

Novel Use of a Polypeptide Comprising Fas-1 Domain

Bladder tumor-targeting peptide and use thereof

Novel use of isolated polypeptide comprising four FAS-1 domains, EM1 domain and RGD motif

Use of a peptide that interacts with αvβ3 integrin of endothelial cell